A detailed history of Nomura Asset Management CO LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 1,040,268 shares of ABT stock, worth $117 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
1,040,268
Previous 970,020 7.24%
Holding current value
$117 Million
Previous $110 Million 1.96%
% of portfolio
0.37%
Previous 0.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $7.08 Million - $7.9 Million
70,248 Added 7.24%
1,040,268 $108 Million
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $17.4 Million - $19.2 Million
-158,875 Reduced 14.07%
970,020 $110 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $2.33 Million - $2.85 Million
25,826 Added 2.34%
1,128,895 $124 Million
Q3 2023

Nov 03, 2023

BUY
$95.53 - $114.62 $6.58 Million - $7.9 Million
68,897 Added 6.66%
1,103,069 $107 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $9.87 Million - $11 Million
97,945 Added 10.46%
1,034,172 $113 Million
Q1 2023

May 11, 2023

BUY
$96.86 - $114.01 $2.57 Million - $3.02 Million
26,511 Added 2.91%
936,227 $94.8 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $5.25 Million - $6.15 Million
55,188 Added 6.46%
909,716 $99.9 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $3.83 Million - $4.43 Million
39,553 Added 4.85%
854,528 $82.7 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $5.06 Million - $6.11 Million
49,552 Added 6.47%
814,975 $88.5 Million
Q1 2022

May 13, 2022

SELL
$114.02 - $139.04 $2.54 Million - $3.1 Million
-22,275 Reduced 2.83%
765,423 $90.6 Million
Q4 2021

Feb 01, 2022

SELL
$115.53 - $141.46 $310,198 - $379,820
-2,685 Reduced 0.34%
787,698 $111 Million
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $6.06 Million - $6.71 Million
51,953 Added 7.04%
790,383 $93.4 Million
Q2 2021

Aug 06, 2021

BUY
$105.79 - $124.53 $33 Million - $38.8 Million
311,752 Added 73.06%
738,430 $85.6 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $14.7 Million - $17.3 Million
-134,914 Reduced 24.02%
426,678 $51.1 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $15.9 Million - $17.3 Million
151,451 Added 36.93%
561,592 $61.5 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $145,615 - $176,839
-1,589 Reduced 0.39%
410,141 $44.6 Million
Q2 2020

Aug 13, 2020

SELL
$76.57 - $98.0 $6.52 Million - $8.35 Million
-85,184 Reduced 17.14%
411,730 $37.6 Million
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $2.37 Million - $3.47 Million
37,782 Added 8.23%
496,914 $39.2 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $88,951 - $99,024
-1,133 Reduced 0.25%
459,132 $39.9 Million
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $2.15 Million - $2.33 Million
26,311 Added 6.06%
460,265 $38.5 Million
Q2 2019

Aug 13, 2019

BUY
$72.88 - $85.0 $298,443 - $348,075
4,095 Added 0.95%
433,954 $36.5 Million
Q1 2019

May 10, 2019

SELL
$66.22 - $80.06 $2.78 Million - $3.36 Million
-42,018 Reduced 8.9%
429,859 $34.4 Million
Q4 2018

Feb 12, 2019

SELL
$65.56 - $74.27 $209,070 - $236,847
-3,189 Reduced 0.67%
471,877 $34.1 Million
Q3 2018

Nov 07, 2018

SELL
$60.81 - $73.36 $277,840 - $335,181
-4,569 Reduced 0.95%
475,066 $34.9 Million
Q2 2018

Aug 03, 2018

BUY
$57.57 - $63.54 $768,098 - $847,750
13,342 Added 2.86%
479,635 $29.3 Million
Q1 2018

May 14, 2018

BUY
$56.27 - $63.62 $414,203 - $468,306
7,361 Added 1.6%
466,293 $27.9 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $1.12 Million - $1.2 Million
-20,852 Reduced 4.35%
458,932 $26.2 Million
Q3 2017

Nov 13, 2017

SELL
$48.06 - $53.64 $916,696 - $1.02 Million
-19,074 Reduced 3.82%
479,784 $25.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
498,858
498,858 $24.3 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.